Justin Ma
Partner
Partner
Languages- Mandarin, English, and Cantonese
Jurisdiction- Hong Kong
Justin has acted for many major investment banks and corporations in corporate finance transactions including Hong Kong initial public offerings, spin-offs, mergers and acquisitions and other listed company compliance matters associated with the Stock Exchange of Hong Kong and the Hong Kong Securities and Futures Commission.
He has extensive experience advising issuers, sponsors and underwriters in initial public offerings on the Hong Kong Stock Exchange, mergers and acquisitions, convertible bond issuance, rights issue and other compliance matters relating to listed companies across different industries including TMT, healthcare and energy.
He has also been involved in a number of overseas initial public offerings in London, Frankfurt, Korea and other places.
Public M&A - Initial public offerings on the Hong Kong Stock Exchange
Acted for Herbs Generation Group Holdings Limited (HKSE:2593) on its initial public offering on the Hong Kong Stock Exchange. ABCI Capital Limited served as the sole sponsor and sole global coordinator for the transaction.
Public M&A - Initial public offerings on the Hong Kong Stock Exchange
Advised joint global coordinators and joint bookrunners CICC, Deutsche Bank and Citigroup, on the US$149 million initial public offering and listing on the Hong Kong Stock Exchange of Inkeverse Group Limited (formerly known as Inke Limited) (HKSE: 37000).
Public M&A – Initial public offerings on the Hon Kong Stock Exchange
Advised Morgan Stanley, JP Morgan, Huatai Financial Holdings (Hong Kong) Limited and UBS, as joint global coordinators and joint bookrunners, on the US$376 million initial public offering and listing on the Hong Kong Stock Exchange of Wise Talent Information Technology Co., Ltd. (HKSE: 6100).
Public M&A - Initial public offerings on the Hon Kong Stock Exchange
Advised co-sponsors and global coordinators Morgan Stanley Asia Limited, Credit Suisse (Hong Kong) Limited and China Merchants Securities (Hong Kong) Limited on the listing on the Main Board of the Stock Exchange of Hong Kong and the global share offering of Meitu, Inc. (HKSE: 1357).
Public M&A - Initial public offerings on the Hong Kong Stock Exchange
Advised Wenzhou Kangning Hospital Co., Ltd. (HKSE: 2120), the largest private psychiatric healthcare group in China in terms of revenue in 2014, on its US$101 million initial public offering on the Hong Kong Stock Exchange. Citigroup Global Market Asia Limited and CITIC CLSA Capital Markets Limited are joint global coordinators on the IPO.
Public M&A - Initial public offerings on the Hon Kong Stock Exchange
Advised China Huarong Asset Management Company Limited (HKSE: 2799), the largest financial asset management company in China by assets, on listing on the Main Board of the Hong Kong Stock Exchange. Goldman Sachs (Asia) Limited, HSBC Corporate Finance (Hong Kong) Limited, China International Capital Hong Kong Securities Limited, Citigroup Global Markets Asia Limited and ICBC International Capital Limited are the joint sponsors on the IPO.
